Topics

Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-Driven Drug Discovery and Disease Diagnosis

08:00 EDT 21 Oct 2019 | EHEALTHNEWS.EU

BayerBayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer's global network of LifeHubs designed to accelerate the co-exploration and development of pioneering solutions to solve global challenges in health and nutrition.

Original Article: Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-Driven Drug Discovery and Disease Diagnosis

NEXT ARTICLE

More From BioPortfolio on "Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-Driven Drug Discovery and Disease Diagnosis"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...